Algal and cyanobacterial secondary metabolites in freshwaters: a comparison of allelopathic compounds and toxins

By J. Leflaive, L. Ten-Hage. 2007

361 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Understanding cyanobacteria‐zooplankton interactions in a more eutrophic world (2014, background): “The production of toxic metabolites, including hepato- or neurotoxins, and various other less known compounds causes lethal and sublethal effects when ingested by zooplankton (Leflaive & Ten-Hage, 2007).”
Harmful algal blooms of allelopathic microalgal species: The role of eutrophication (2008, background): “The cyanobacterium C. raciborskii has recently been suggested as an allelopathic species (Leflaive and Ten-Hage, 2007).”
Still challenging: the ecological function of the cyanobacterial toxin microcystin – What we know so far (2018, background): “…strains exploit the available extracellular toxins produced by the toxic genotypes in blooms, or they might produce other metabolites with the similar chemical structure but which are not toxic such as cyanopeptolines or microginins (Leflaive & Ten-Hage, 2007; Namikoshi & Rinehart, 1996).”
Current Approaches for Enhanced Expression of Secondary Metabolites as Bioactive Compounds in Plants for Agronomic and Human Health Purposes – a Review (2013, background): “Among allelochemicals some compounds that have been shown to have bioactivity as antibiotic, antifungal and anti-predator activities are allelopathic compounds [Lefl aive & Ten-Hage, 2007].”